Akiya - Diphtheria

Embed Size (px)

Citation preview

  • 8/3/2019 Akiya - Diphtheria

    1/52

    DIPHTHEDIPHTHE

    RIARIA

  • 8/3/2019 Akiya - Diphtheria

    2/52

    An acute, highly

    contagious toxin-mediatedinfection caused by

    Corynebacteriumdiphtheriae, a gram-

    positive, aerobic rod that

    usu. infects the respiratorytract; primarily the tonsils,

    nasopharynx, & larynx,

  • 8/3/2019 Akiya - Diphtheria

    3/52

  • 8/3/2019 Akiya - Diphtheria

    4/52

    Infected humans

    Weakened

    Humans

    C. diphtheriae

    Discharges from mucous

    membranes of

    nose and nasopharynx,

    skin, & other lesions

    Airborne droplets,

    direct

    contact,

    contaminated

    fomites, & raw milk

    Respiratory

    Integumentary

    CHAIN

    OFINFECTIO

    N

    INCUBATION

    PERIOD: Usu.

    2-5 days,

    possibly longer

  • 8/3/2019 Akiya - Diphtheria

    5/52

    HUMANANATOMYHUMANANATOMY

    & PHYSIOLOGY& PHYSIOLOGY

    (UpperRespiratory(UpperRespiratory

    Tract)Tract)

  • 8/3/2019 Akiya - Diphtheria

    6/52

  • 8/3/2019 Akiya - Diphtheria

    7/52

    RISKRISK

    FACTORFACTORSS

  • 8/3/2019 Akiya - Diphtheria

    8/52

    PREDISPOSING RISKFACTORS:

    Poor sanitation

    Crowded living conditions

    Limited access to healthcare

    Lack of periodic boosterimmunizations

  • 8/3/2019 Akiya - Diphtheria

    9/52

    PRECIPITATING RISKFACTORS:

    Direct contact with infected

    person, carrier, orcontaminated articles

    Use of contaminated objects

    from diphtheria-infected people Ingestion of unpasteurizeed

    milk

  • 8/3/2019 Akiya - Diphtheria

    10/52

    PATHOGENPATHOGEN

    ESISESIS

  • 8/3/2019 Akiya - Diphtheria

    11/52

    Colonizes in the

    mucosal surface &

    multiply

    Bacteria release a toxin

    Diphtheria toxin is

    absorbed to themucous membranes

    Destruction of

    epithelium (tissue

    necrosis

    RISK FACTORS

  • 8/3/2019 Akiya - Diphtheria

    12/52

    Embedded in exuding

    fibrin & red & white cells

    Psuedomembrane

    formation

    DIPHTHERIANASAL:

    Resembles common cold;serosanguineous

    mucopurulent nasal

    discharge w/o constitutional

    symptoms

  • 8/3/2019 Akiya - Diphtheria

    13/52

    TONSILLAR/PHARYNGEAL:

    Thick, patchy, smooth, adherent white/

    grayish memrane over the mucous

    Low-grade fever

    Malaise

    Anorexia

    Headache Sore throat

    Malodorous breath

    Dysphagia

    Swollen & tender cervical lymph nodes(lymphadenitis) possibly pronounced w/

    warm & swollen neck (bulls neck)

    Increased weak pulse

  • 8/3/2019 Akiya - Diphtheria

    14/52

    LARYNGEAL:

    Fever

    Hoarseness

    Rasping cough (and other symptoms similar to

    croup)

    W/ or w/o other sings listed

    (potential airway obstruction)

    Restlessness

    Apprehensive

    Dyspneic (suprasternal) retractions

    Tachypnea

    Cyanosis

    Stridor

  • 8/3/2019 Akiya - Diphtheria

    15/52

    CUTANEOUS:

    Skin lesions resemble

    impetigo

  • 8/3/2019 Akiya - Diphtheria

    16/52

    CLINICALCLINICAL

    MANIFESTATIOMANIFESTATIONSNS

  • 8/3/2019 Akiya - Diphtheria

    17/52

    Headache

  • 8/3/2019 Akiya - Diphtheria

    18/52

    Low-

    grade

    fever

  • 8/3/2019 Akiya - Diphtheria

    19/52

    Anorexia

  • 8/3/2019 Akiya - Diphtheria

    20/52

    Thick, patchy,smooth,

    adherent

    white/ grayish

    memrane

    over themucous

  • 8/3/2019 Akiya - Diphtheria

    21/52

  • 8/3/2019 Akiya - Diphtheria

    22/52

    Swollen & tender cervical lymph nodes

    (lymphadenitis) possibly pronounced w/

    warm & swollen neck (bulls neck)

  • 8/3/2019 Akiya - Diphtheria

    23/52

    Skin lesions resemble impetigo

  • 8/3/2019 Akiya - Diphtheria

    24/52

    SIMPLE CRITICAL THINKING:

    As a nurse caring for a patient

    with diphtheria, what should bekept at bedside?

  • 8/3/2019 Akiya - Diphtheria

    25/52

    Suction equipment,Tracheostomy tray andEpinephrine

  • 8/3/2019 Akiya - Diphtheria

    26/52

    DIAGNDIAGN

    OSISOSIS

  • 8/3/2019 Akiya - Diphtheria

    27/52

    Examination showing the

    characterisic membrane and athroat culture, or culture ofother suspect lesions growing

    C. diptheriae in an enzyme-linked immunosorbentasssay( E:LISA) orthe Elek

    test (toxigencity test),confirm the diagnosis. Gram-stain or immunofluorescent

    antibody stains may also be

  • 8/3/2019 Akiya - Diphtheria

    28/52

    THERAPEUTICTHERAPEUTIC

    MANAGEMENTMANAGEMENT

  • 8/3/2019 Akiya - Diphtheria

    29/52

    Diphtheria antitoxin (IM; usu.

    IV); preceded by skin orconjunctival test to r/o

    sensitivity to horse serum

    Antibiotics (penicillin/erythromycin)

    CB

    R(for prevention ofmyocarditis)

    Tracheostomy for airway

    obstruction

  • 8/3/2019 Akiya - Diphtheria

    30/52

  • 8/3/2019 Akiya - Diphtheria

    31/52

  • 8/3/2019 Akiya - Diphtheria

    32/52

    COMPLICATICOMPLICATI

    ONSONS

  • 8/3/2019 Akiya - Diphtheria

    33/52

    o Thrombocytopenia

    oNeurologic involvement(primarily affecting motor fibers

    but possibly also sensory

    neurons)

    o Renal involvement

    o Pulmonary involvement(bronchopneumonia)

    o Myocarditis (2nd wk.)

  • 8/3/2019 Akiya - Diphtheria

    34/52

    NURSINGNURSING

    CONSIDERATICONSIDERATIONSONS

  • 8/3/2019 Akiya - Diphtheria

    35/52

    Preventing Spread of

    Infection

    Maintain and stress the need

    for strict isolation in hospital

    Teach proper disposal ofnasopharyngeal secretions

    Maintain infection precautions

  • 8/3/2019 Akiya - Diphtheria

    36/52

    SIMPLE CRITICAL

    THINKING: When can

    we say a patient is

    free from C.

    diphtheriae?

  • 8/3/2019 Akiya - Diphtheria

    37/52

    Maintain infection precautionsuntil after three consecutive

    negative cultures at least 24hours apart, with the firstculture being at least 24 hours

    after the completion ofantimicrobial therapy.

  • 8/3/2019 Akiya - Diphtheria

    38/52

    SIMPLE CRITICAL

    THINKING:How about

    those whom the patient

    had close contact with?

  • 8/3/2019 Akiya - Diphtheria

    39/52

    Nasopharyngeal and throat cultures are alsoobtained from all close contacts.

    Symptomatic clients are isolated andtreated until two negative throat culturesare obtained.

    Asymptomatic disease carriers areconfined to home until at least 3 days ofantibiotic therapy have been completed.

    Booster shots are given to people who

    were immunized 5 or more yearspreviously. Unimmunized contacts aretreated with immunization andantibiotics.

    All contacts, including hospital personnel,

  • 8/3/2019 Akiya - Diphtheria

    40/52

    Monitoring and Preventing

    Complications

    Administer complete care tomaintain bed rest

    Observe respiration for signsof obstruction (esp. inlaryngeal diphtheria) and beready to give immediate lifesupport, including intubation &tracheostomy

  • 8/3/2019 Akiya - Diphtheria

    41/52

    Be alert for signs ofmyocarditis, such as

    development of heart murmursorECG changes. Ventricularfibrillation is a common causeof sudden death in diphtheriapatients

    Watch for signs of shock, w/ccan develop suddenly

    If neuritis develops, tell thepatient its usually transient. Beaware that peripheral neuritis

    may not develop until 2 to 3

  • 8/3/2019 Akiya - Diphtheria

    42/52

    Patient Comfort

    Limit the diet to liquids and soft

    foods

    Throat irrigation and fluids

  • 8/3/2019 Akiya - Diphtheria

    43/52

    Collaborative Nursing

    Considerations Have patient participated insensitivity testing; haveepinephrine (1:1,000) readilyavailable

    Give drugs as ordered. Aftergiving antitoxin or penicillin, be

    alert for anaphylaxis; keepepinephrine 1: 1,000 andresuscitation handy. In patients

    who receive erythromycin,

  • 8/3/2019 Akiya - Diphtheria

    44/52

    Use suctioning as neededAdminister humidified 02 if

    prescribed

    Serial ECGs should beperformed twice weekly for4to 6 weeks to watch for

    myocarditis Obtain cultures as ordered

  • 8/3/2019 Akiya - Diphtheria

    45/52

    Stress the need for childhood

    immunizations to all parents.

    Report all cases of diphtheriato local public health

    authorities.

    Prevention

  • 8/3/2019 Akiya - Diphtheria

    46/52

    SIMP

    LE

    RECALL:What is the

    schedulingofdiphtheria

    immunization basedfrom EPI?

  • 8/3/2019 Akiya - Diphtheria

    47/52

    At 6 weeks, infants are given 0.5mL ofDPT vaccine IM at upper

    outer portion of the thigh.T

    hisimmunization has 3 doses with4 weeks interval..

  • 8/3/2019 Akiya - Diphtheria

    48/52

    Diphtheria infection doesntconfer immunity, therefore

    diphtheria immunization shouldbe given duringconvalescence.

  • 8/3/2019 Akiya - Diphtheria

    49/52

    RELATEDRELATED

    JOURNALJOURNALSS

  • 8/3/2019 Akiya - Diphtheria

    50/52

    Effect of a single tetanusEffect of a single tetanus--diphtheriadiphtheria

    vaccine dose on the immunity of elderlyvaccine dose on the immunity of elderly

    people in SoP

    aulo, Brazilpeople in SoP

    aulo, BrazilAbstractEpidemiological data regarding tetanus and diphtheriaimmunity in elderly people in Brazil are scarce. During the FirstNational Immunization Campaign for the Elderly in Brazil inApril 1999, 98 individuals (median age: 84 years) received onetetanus-dyphtheria (Td) vaccine dose (Butantan Institute, lotnumber 9808079/G). Inclusion criteria were elderly individualswithout a history of severe immunosuppressive disease, acuteinfectious disease or use of immunomodulators. Bloodsamples were collected immediately before the vaccine and 30days later. Serum was separated and stored at -20oC untilanalysis. Tetanus and diphtheria antibodies were measured bythe double-antigen ELISA test. Tetanus and diphtheriaantibody concentrations lower than 0.01 IU/mL wereconsidered to indicate the absence of protection, between 0.01and 0.09 IU/mL were considered to indicate basic immunity,and values of 0.1 IU/mL or higher were considered to indicatefull protection. Before vaccination, 18% of the individuals weresusceptible to diphtheria and 94% were susceptible to tetanus.

    After oneT

    d dose, 78% became fully immune to diphtheria,13% attained basic immunity, and 9% were still susceptible to

  • 8/3/2019 Akiya - Diphtheria

    51/52

    Although one Td dose increases immunity to diphtheria

    in many elderly people who live in Brazil, a complete

    vaccination series appears to be necessary for the

    prevention of tetanus.

    Key words:E

    lderly,T

    etanus,D

    iphtheria, Immunization

  • 8/3/2019 Akiya - Diphtheria

    52/52

    Fin.Fin.